Free Trial

Precipio (PRPO) Competitors

Precipio logo
$5.10 -0.05 (-1.07%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PRPO vs. CLIR, AXDX, DAIO, STAI, ASTC, BNGO, TLIS, TBIO, SMIT, and SPEC

Should you be buying Precipio stock or one of its competitors? The main competitors of Precipio include ClearSign Technologies (CLIR), Accelerate Diagnostics (AXDX), Data I/O (DAIO), Scantech AI Systems (STAI), Astrotech (ASTC), Bionano Genomics (BNGO), Talis Biomedical (TLIS), Telesis Bio (TBIO), Schmitt Industries (SMIT), and Spectaire (SPEC). These companies are all part of the "measuring and control equipment" industry.

Precipio vs.

Precipio (NASDAQ:PRPO) and ClearSign Technologies (NASDAQ:CLIR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Precipio has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500. Comparatively, ClearSign Technologies has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500.

10.4% of Precipio shares are owned by institutional investors. Comparatively, 24.0% of ClearSign Technologies shares are owned by institutional investors. 13.3% of Precipio shares are owned by company insiders. Comparatively, 16.9% of ClearSign Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Precipio and Precipio both had 6 articles in the media. ClearSign Technologies' average media sentiment score of 0.90 beat Precipio's score of 0.44 indicating that ClearSign Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precipio
1 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ClearSign Technologies
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Precipio received 120 more outperform votes than ClearSign Technologies when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 41.08% of users gave ClearSign Technologies an outperform vote.

CompanyUnderperformOutperform
PrecipioOutperform Votes
272
73.32%
Underperform Votes
99
26.68%
ClearSign TechnologiesOutperform Votes
152
41.08%
Underperform Votes
218
58.92%

ClearSign Technologies has lower revenue, but higher earnings than Precipio. ClearSign Technologies is trading at a lower price-to-earnings ratio than Precipio, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precipio$17.41M0.45-$5.85M-$2.94-1.80
ClearSign Technologies$4.28M6.13-$5.19M-$0.11-4.75

ClearSign Technologies has a consensus price target of $6.00, suggesting a potential upside of 1,049.43%. Given ClearSign Technologies' stronger consensus rating and higher possible upside, analysts plainly believe ClearSign Technologies is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
ClearSign Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Precipio has a net margin of -17.23% compared to ClearSign Technologies' net margin of -118.93%. Precipio's return on equity of -34.01% beat ClearSign Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Precipio-17.23% -34.01% -25.27%
ClearSign Technologies -118.93%-50.44%-41.41%

Summary

ClearSign Technologies beats Precipio on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get Precipio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRPO vs. The Competition

MetricPrecipioAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$7.83M$4.06B$5.33B$7.13B
Dividend YieldN/A0.54%4.87%4.05%
P/E Ratio-2.8926.4522.8917.40
Price / Sales0.454.06357.5184.53
Price / CashN/A36.2738.1634.64
Price / Book0.521.586.253.79
Net Income-$5.85M-$83.57M$3.21B$247.10M
7 Day Performance-10.21%-6.79%-8.04%-7.61%
1 Month Performance-26.19%-13.25%-2.99%-10.32%
1 Year Performance-16.38%-39.15%3.54%-7.75%

Precipio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRPO
Precipio
0.5742 of 5 stars
$5.27
+2.3%
N/A-18.4%$7.81M$17.41M-2.8860Short Interest ↑
CLIR
ClearSign Technologies
2.5202 of 5 stars
$0.77
-1.1%
$6.00
+683.0%
-38.6%$38.49M$4.28M-6.9710Earnings Report
Analyst Forecast
Gap Down
AXDX
Accelerate Diagnostics
1.4846 of 5 stars
$1.04
-1.9%
$1.00
-3.8%
-23.2%$26.05M$11.91M-0.36220Analyst Forecast
Gap Down
High Trading Volume
DAIO
Data I/O
1.676 of 5 stars
$2.47
-1.4%
$4.00
+62.3%
-30.5%$22.77M$21.77M-12.97100
STAI
Scantech AI Systems
N/A$2.61
-7.1%
N/AN/A$11.68M$522,166.000.00N/APositive News
Gap Up
ASTC
Astrotech
1.0053 of 5 stars
$6.40
-1.4%
N/A-27.7%$10.89M$419,000.00-0.7810
BNGO
Bionano Genomics
1.3114 of 5 stars
$3.30
+1.5%
$90.00
+2,627.3%
-94.5%$8.88M$33.33M-0.02300Analyst Forecast
Gap Down
TLIS
Talis Biomedical
N/A$1.74
+8.1%
N/A-81.5%$3.17M$300,000.00-0.06260
TBIO
Telesis Bio
N/A$0.39
flat
N/A-96.7%$703,000.00$225.09M-0.01200
SMIT
Schmitt Industries
N/A$0.02
flat
N/A-39.3%$69,000.00$9.89M0.00160
SPEC
Spectaire
N/A$0.00
-9.1%
N/A-99.9%$18,000.00N/A0.008
Remove Ads

Related Companies and Tools


This page (NASDAQ:PRPO) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners